跳至主要内容
临床试验/JPRN-jRCT2080221521
JPRN-jRCT2080221521未知1 期

A Phase I, Randomized, Double-Blind, Placebo-Controlled Trial of Single and Multiple Doses of TAS-114 in Healthy Adult Male Subjects

Taiho Pharmaceutical Co., Ltd.0 个研究点目标入组 35 人开始时间: 2011年7月25日最近更新:
适应症

试验速览

阶段
1 期
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 39age old(—)
性别
Male

入选标准

  • Healthy male subject who have given written informed consent
  • - Subject's age of twenty years old or more and less than forty years old
  • - Subject's weight of 50.0kg or more and BMI (Body Mass Index) of 18.0-25.0kg/m2

排除标准

  • - Subject with a history or concurrent status of allergic reaction
  • - Subject with a history or concurrent status of alcoholic or drug addiction
  • - Subject who is not willing to stop smoking during hospitalization
  • - Subject who recieved other investigational drug within 180 days before receiving the study drug

研究者

相似试验